2000 Annual Report
Treasurer's Report and Dana-Farber Governance
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND CHANGES IN NET ASSETS
|
For the Fiscal Year Ended Sept. 30
(Dollars in thousands)
|
2000
|
1999
|
|
|
Revenues
|
|
|
|
Research
|
116,066
|
$103,974
|
|
Patient Service, net
|
112,770
|
91,541
|
|
Unrestricted Jimmy Fund Contributions and Bequests
|
23,899
|
18,920
|
|
Other Operating
|
12,480
|
11,088
|
|
Total Revenues
|
265,215
|
225,523
|
|
|
Expenses
|
|
|
|
Direct Research
|
94,782
|
80,930
|
|
Direct Patient Care
|
98,398
|
71,410
|
|
Indirect
|
99,429
|
94,061
|
|
Total Operating Expenses
|
281,608
|
246,401
|
|
|
Deficit Before Investment Return
|
(16,393)
|
(20,878)
|
|
Realized Investment Return, net
|
41,691
|
29,590
|
|
Excess of Revenues Over Expenses
|
25,298
|
8,712
|
Net Unrealized Investment Gains (Losses) |
14,530
|
17,155
|
|
Net Assets Released from Restrictions for Capital
|
345
|
434
|
|
Other Transfers
|
(1,367)
|
—
|
|
Increase (Decrease) in Temporarily Restricted Net Assets
|
39,299
|
19,345
|
|
(Decrease) Increase in Permanently Restricted Net Assets
|
7,700
|
(12,968)
|
|
Increase (Decrease) in Net Assets
|
85,805
|
32,678
|
|
Net Assets at Beginning of Year
|
395,140
|
362,462
|
|
|
Net Assets at End of Year
|
480,945
|
$395,140
|
|
The preceding selected consolidated financial data as of September 30, 2000, and 1999 and for each of the years then ended, except for the Summary Statistical Data, have been derived from the consolidated financial statements of Dana-Farber Cancer Institute, Inc., and Dana-Farber, Inc., which have been audited by Ernst & Young, LLP, independent auditors.
Paths of Progress, Winter/Spring 2001
Paths of Progress Archive
